Dr. Adi Gidron, MD

Dr. Gidron practices at Presence St. Francis Hospital- Evanston in Evanston, Illinois.

Dr. Gidron's NPI, 1184767444, was assigned on February 15, 2007. Dr. Gidron graduated from Northwestern University Feinberg Medical School in 2001. Dr. Gidron holds Illinois license 036110781.

Dr. Gidron's primary practice is Presence St. Francis Hospital- Evanston, at 355 Ridge Ave, Evanston, IL 60202 in Cook County. The practice phone is (847) 316-4000.

Dr. Gidron's primary practice is Presence St. Francis Hospital- Evanston in Evanston, Illinois. Dr. Gidron is also affiliated with Evanston Hospital. The medical group on file is Prime Healthcare Illinois Medical Group. Dmand AI also links Dr. Gidron to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gidron practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gidron's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gidron is licensed in Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Gidron treats.

CMS data shows 1,282 Medicare services from Dr. Gidron across 7 procedure codes in 2024, for 386 Medicare patients. Medicare paid $86,223 for them.

CMS counts 386 Medicare patients who saw Dr. Gidron in 2024. The largest group is 65 to 74, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gidron's median patient age at 73, with 59% women.

In 2024, Dr. Gidron wrote 1,150 Medicare Part D claims for 169 patients. 74% of them were for generic drugs. CMS names the drug for 877 of them, across 32 drugs with 11 or more claims each, at $2,186,104 in total drug cost. In 2023, CMS named 899 claims across 32 drugs.

Dr. Gidron accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Gidron, published from 2007 to 2022. 2021 was the busiest year, with 4. The most frequent topics are Antigens, CD34, Antineoplastic Combined Chemotherapy Protocols and Leukemia, Hairy Cell. Dr. Gidron has published most often in Bone Marrow Transplant. Dr. Gidron's most frequent co-authors are Martin S. Tallman, MD, Nagwa M. Abou-Ghanem, MD and Dana Ioana Vais, MD.

CMS Open Payments shows 57 general payments to Dr. Gidron from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Genentech, Inc. paid the most, $144.

Dmand AI lists 1 award for Dr. Gidron, most recently CMS Stage 1 EHR in 2013.

Dr. Gidron graduated from Northwestern University Feinberg Medical School in 2001.

Dr. Gidron is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.